JPMorgan Chase & Co’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $146K | Buy |
70,067
+16,702
| +31% | +$34.9K | ﹤0.01% | 4621 |
|
|
2025
Q1 | $91K | Buy |
53,365
+2,721
| +5% | +$4.64K | ﹤0.01% | 4781 |
|
|
2024
Q4 | $256K | Sell |
50,644
-1,191
| -2% | -$6.02K | ﹤0.01% | 4437 |
|
|
2024
Q3 | $282K | Sell |
51,835
-356
| -0.7% | -$1.94K | ﹤0.01% | 4314 |
|
|
2024
Q2 | $251K | Buy |
52,191
+4,360
| +9% | +$20.9K | ﹤0.01% | 4165 |
|
|
2024
Q1 | $149K | Sell |
47,831
-14,141
| -23% | -$44K | ﹤0.01% | 4577 |
|
|
2023
Q4 | $176K | Buy |
61,972
+377
| +0.6% | +$1.07K | ﹤0.01% | 4513 |
|
|
2023
Q3 | $180K | Buy |
61,595
+8,069
| +15% | +$23.6K | ﹤0.01% | 4284 |
|
|
2023
Q2 | $153K | Buy |
53,526
+2,548
| +5% | +$7.29K | ﹤0.01% | 4427 |
|
|
2023
Q1 | $157K | Buy |
50,978
+13,676
| +37% | +$42.1K | ﹤0.01% | 4445 |
|
|
2022
Q4 | $79K | Buy |
37,302
+19,784
| +113% | +$41.9K | ﹤0.01% | 4572 |
|
|
2022
Q3 | $58K | Buy |
17,518
+2,932
| +20% | +$9.71K | ﹤0.01% | 4657 |
|
|
2022
Q2 | $47K | Buy |
14,586
+2,034
| +16% | +$6.55K | ﹤0.01% | 4867 |
|
|
2022
Q1 | $89K | Sell |
12,552
-1,846
| -13% | -$13.1K | ﹤0.01% | 4795 |
|
|
2021
Q4 | $105K | Buy |
+14,398
| New | +$105K | ﹤0.01% | 4805 |
|